Skip to main content

Table 3 Sources of input parameters and results

From: Does health economics research align with the disease burden in the Middle East and North Africa region? A systematic review of economic evaluation studies on public health interventions

Author (references)

Source of cost data

Source of epidemiological data

Source of effectiveness data

Source of utility data

Source of funding

Threshold

ICER and results

Conclusion

Adibi et al. [21]

Iranian

Iranian, international and expert consensus

International

NA

Academia

1 GDP (US$ 1790 in 2003)

The cost/CHB infection averted was US$ 202 and 197 for the strategies 1 and 2, respectively

Premarriage prevention of HBV transmission in Iran seems cost saving

Al Abri et al. [22]

Omani and international

Omani and international

International

International

Industry

WTP of US$ 100,000 in 2020

The QFT-Plus with 3HP was more cost-effective than the other TB strategies with an ICER of US$ 2915/QALY gained. The CXR strategy was the least cost-effective

IGRA testing followed by 3HP is the most cost-effective intervention

Al‐Qudah et al. [23]

Jordanian and assumption

Jordanian

International

NA

None

NA

Benefit‐to‐cost ratio was 5.98 and an annual net benefit was US$ 64,393

Clinical pharmacist intervention is cost beneficial and offers substantial cost savings to the healthcare payer

Assanelli et al. [24]

Algerian

International

International

NA

Industry

NR

The total cost in Algeria was $PPP 79,395, total cost/athlete was $PPP 74.10, and CER of screening was $PPP 582

Results strongly support the utilization of 12-lead ECG in the pre participation screening of young athletes

Balicer et al. [25]

Local

International

International

NA

NR

NA

Therapeutic treatment and postexposure prophylaxis were shown to be cost-saving, with a cost–benefit ratio of 2.44–3.68

Pre pandemic stockpiling of Oseltamivir is cost-saving to the economy and to the healthcare system, if the use is limited to treat patients at high risk

Barfar et al. [26]

Iranian

Iranian

International

NA

Government

NR

ICER/breast cancer detected was US$ 15,742

Mammography screening program is not cost-effective

Carvalho et al. [27]

WHO CHOICE, donors and local

Afghan and international

NR

NA

NGO

1–3 GDP/C (US$ 500–1500 in 2009/10)

ICERs of family planning strategies were below US$ 130/LYG. ICERs of stepwise improvements in maternal health services were below US$ 200/LYG

The combination of investment in reproductive health infrastructure and increase in family planning is highly cost-effective

Chodick et al. [28]

Local and international

Local

International

NA

NR

NR

The incremental cost of screening and vaccination of susceptible workers was US$ 23,713/avoided case, serological tests was US$ 206,692/avoided case, and vaccinating all HCWs without serotesting wad US$ 10.4 million/avoided case

Screening and vaccination of susceptible workers using anamnestic selection are cost-effective while screening alone and mass vaccination alone of all HCWs without serotesting are not cost-effective

Chodick et al. [29]

Local and international

Local and international

International

International

Government

US$ 60,000

Screening prior vaccination among 18- to 39-year-old physicians and paramedical workers achieved the lowest cost per prevented Hepatitis A case (US$ 6240 and 6773, respectively). ICERs/QALY were US$ 56,532 and 61,350 for the same groups

Screening followed by selective vaccination for physicians and for paramedical workers is recommended

Chowers [30]

Local

Local and international

International

Local and international

NR

1–3 GDP/C (US$ 28,667–86,000) in 2014)

Universal prenatal screening dominates over the current policy with an ICER of (US$ -11,546)/QALY gained

Universal prenatal HIV screening is projected to be cost saving

Devine [31)

International

International

International

International

Government, academia and NGO

1 GDP/C

The ICERs were US$ 18.6 for 14-day Primaquine (without G6PD screening), US$ 1089 for Tafenoquine in male and 7-day Primaquine in female (both with G6PD screening)

Using a gender-based treatment strategy could significantly change the landscape for providing the radical cure of Plasmodium vivax Malaria

El-Dahiyat [32]

Jordanian

NA

NA

NA

None

NA

The average savings if using the generic drugs instead of the originator brand medicines in Jordan was 32.68%, and the maximum savings was 74.29%

Generic substitution can provide significant savings to patients and healthcare system

El-Ghitany [33]

Egyptian

Egyptian

NR

NA

None

NR

Using EGCRISC would save LE 0.43 billion accounting for about 21,646,227 unnecessary tests

EGCRISC is a cost-effective tool that must be adopted nationwide

Eltabbakh et al. [34]

Egyptian

NR

NR

International

NR

1–3 GDP/C (US$ 3184–9553)

ICER was not reported. The costs were US$ 1105 and 1180/QALY for screening with ultrasound only and for both ultrasound and alpha-fetoprotein, respectively

Screening for HCC is highly cost-effective

Gamaoun et al. [35]

Tunisian, international and estimations

Tunisian and international

Tunisian and international

NA

NR

NR

The incremental cost of cervical cancer screening according to 10-year periodicity was US$ 8219, 5-year periodicity was US$ 14,567, 3-year periodicity was US$ 20,479, and finally the national vaccination program was US$ 36,854 per avoided cervical cancer case

Cervical cancer screening each 5 years combined with scheduled two-dose anti-HPV national vaccination program is the best cost-effective strategy for cervical cancer prevention

Ginsberg et al. [36]

Local and assumptions

Local

Local and international

NA

NR

NA

The benefit–cost ratio of the program to the health services was 4.22:1 which increased to 6.01:1 when a societal perspective was taken

The monetary benefits of a nationwide thalassemia screening program to society and to the healthcare system exceeds the program's costs

Ginsberg et al. [37]

Local

Local and international

International

International

NR

1–3 GNP/C (US$ 27,055–81,165 in 2010)

ICER/DALY averted was US$ 2509 for Pap smear screening of females at age 40, US$ 10,543 for thrice a lifetime VIA, US$ 22,841 for three doses HPV vaccination at age 12 plus a booster dose at ages 32 and 52 combined with penta-annual Pap smear screening for females aged 20–65, and US$ 30,029 for addition of penta-annual HPV DNA screening to vaccination and penta-annual Pap smear

HPV screening interventions combined with vaccination program have the potential to be very cost-effective

Ginsberg et al. [38]

Local

Local

International

International

None

1–3 GDP/C (US$ 40,439–121,316 in 2017)

ICER of HIV pre-exposure prophylaxis drugs was around US$ 967,744/averted DALY

HIV pre-exposure prophylaxis drugs were found not to be cost-effective. Prices would have to fall by 90.7% for the intervention to become cost-effective

Ginsberg et al. [39]

Local and international

Local

International

NR

NR

1–3 GDP/C (US$ 20,366–61,098 in 2007)

ICER/QALY gained were US$ 65,024 for annual Pap smear, US$ 35,403 for tri-annual Pap smears, US$ 28,612 for penta-annual Pap smears, US$ 9,273 for thrice a lifetime Pap smears, US$ 48,660 for tri-annual Pap smears with HPV-DNA testing, US$ 33,705 for penta-annual combination, US$ 46,807 for a thrice a lifetime HPV-DNA testing, US$ 61,264 for thrice a lifetime VIA, US$ 81,404 for one-off HPV vaccination females aged 12, US$ 272,010 for vaccinating females every 10 years from age 12 to 62

All HPV screening interventions are cost effective or highly cost-effective except for annual Pap smear and a thrice a lifetime VIA. HPV vaccination program is not cost-effective as well

Ginsberg et al. [40]

Local and international

Local

NA

NR

NR

1–3 GNP/C (NIS 104,161–312,483 in 2010)

Implementation of the cluster of interventions would save 32,671 QALYs at a cost of NIS 47,559/QALY

Fielding an eight-pronged combined clinical and community-based dietary interventional program is very cost-effective

Haghighat et al. [41]

Iranian

Iranian and international

Iranian

International

None

1–3 GDP/C (Int. $ 13,100–39,300 in 2012)

ICERs of mammography screening were Int. $ 37,350, Int. $ 141,641 and Int. $ 389,148/QALY gained in the first, second and third rounds of screening program, respectively

Mammography screening program is cost effective in 53% of the cases, but ICER/QALY in the second and third rounds of screening are not cost-effective

Hamdani et al. [42]

Pakistani

Pakistani

Pakistani

NA

Government

US$ 67

The mean ICER to successfully treat a case of depression using an international supervisor was US$ 517 compared with US$ 102.93 using a local one

The Problem Management + is more effective but also more costly

Howard et al. [43]

Pakistani

Pakistani and international

NR

Afghan

None

1–3 GDP/C (US$ 479–1436 in 2015)

The additional cost of including indoor residual spraying over five years per case prevented was US$ 39 (50 for Vivax and 182 for Falciparum). Per DALY averted this was US$ 266

Adding indoor residual spraying is cost-effective

Hussain et al. [44]

Pakistani

NR

International

International

NGO

NR

Incentive-based active case finding program costs US$ 223 per patient treated and incrementally averted 0.17 DALYs at the cost of US$ 15.74 over 6 months

Both screening strategies appear to be cost-effective in an urban Pakistani context

Javadinasab et al. [45]

Iranian

Iranian and international

Iranian and international

International

NR

1–3 GDP/C (US$ 5442–16,326 in 2014)

In CUA, compared with no screening, the ICERs/QALY gained were US$ 489 for one screening/lifetime at age 50, US$ 709 for one screening/lifetime at age 55, US$ 1010 for screening every 10 years starting at age 50, US$ 1386 for screening every 10 years starting at age 40, US$ 2310 for screening every 5 years starting at age 50 and US$ 3135 for screening every 5 years starting at the age of 40.

In CEA, compared with no screening, the ICERs/LYG gained were US$ 725 for one screening/lifetime at age 50, US$ 1115 for one screening/lifetime at age 55, US$ 1540 for screening every 10 years starting at age 50, US$ 1995 for screening every 10 years starting at age 40, US$ 3508 for screening every 5 years starting at age 50, and US$ 4489 for screening every 5 years starting at the age of 40

Colorectal cancer colonoscopy screening in high-risk individuals is cost-effective in Iran. Colonoscopy screening every 10 years starting at the age of 40 is the most cost-effective strategy

Javanbakht [46]

Iranian

Iranian and international

NA

NA

Academia

NR

The estimated savings in health cost per capita were US$ 0.43, 8.42, 39.97 and 190.25 in 1, 5, 10 and 20-years’ time horizons, respectively. Corresponding total aggregated avoidable costs for entire population were US$ 33.83 million, 661.31 million, 3138.21 million and 14,934.63 million, respectively

Increasing dairy foods consumption to recommended levels would be associated with reductions in healthcare costs

Kashi et al. [47]

Estimation

International

International

International

NGO

1–3 GDP/C

The ICER of transitioning from iron and folic acid supplementation to multiple micronutrient supplementation was US$ 41.54/DALY in Pakistan

Multiple micronutrient supplementation is cost-effective and generates positive health outcomes for both infants and pregnant women

Khneisser et al. [48]

Lebanese

Lebanese

NR

NA

Academia

NA

A reduction by half of direct cost of care, reaching on average US$ 31,631 per detected case was shown. This difference more than covers the expense of starting a newborn screening program

Direct and indirect costs saved through early detection of these disorders are important enough to justify universal publicly-funded screening, especially in developing countries with high consanguinity rates

Khneisser et al. [49]

Lebanese

Lebanese

NR

NA

Academia

NA

The cost–benefit index of systematic screening was about 2.58 times lower than that of anemia-related hospitalizations in an unscreened population

The efficiency of routinely testing described in this study supports changes in screening policies for boys

Kim et al. [50]

Egyptian

Egyptian and international

Egyptian and international

International

Academia

1–3 GDP/C (US$ 3333–10,000 in 2014)

No screening would cost US$ 1840 for 19.179 QALYs. Implementing a screening program using triple-therapy was dominant compared to no screening because it would have lower total costs (US$ 1816) and lead to higher QALYs (19.229)

Screening and treatment programs for HCV in Egypt can be cost-effective methods to reduce the burden of liver disease

Kim et al. [51]

Local, regional and assumption

Local and international

Local and international

International

NGO and public

1 GDP/C (Int. $ 7521 in Algeria, 12,605 in Lebanon and 12,540 in Turkey; all in 2010 values)

Cytology-based screening alone was less cost effective, in Lebanon, Turkey and Algeria. The CER for combined vaccination and cytology screening was Int. $ 7520 in Algeria and 12,540 in Turkey while it was not cost-effective in Lebanon

Annual cytology screening is not cost-effective. Promoting organized, less frequent (3–5 years) screening and adopting HPV DNA testing can result in more efficient cervical cancer prevention efforts

Koren et al. [52]

Local

Local

NR

NA

Industry

NR

The cost of preventing one affected newborn was US$ 63,660 compared to 1,971,380 for treatment of a patient during 50 years

Implementation of a national β Thalassemia prevention program appears cost-effective

Lahiri et al. [53]

Local, regional and assumptions

International

International

NA

NGO

NR

In all of the sub-regions, training was the most cost-effective with CER of US$ 74 per LYG in the sub-region comprising of Egypt, Iraq, Morocco and Yemen so it would be the first choice option where resources are scarce

Worker training is a low cost and feasible first step toward reducing back pain/injury incidence. However, the engineering controls interventions as well as the full ergonomics program look very cost effective for all of the WHO sub-regions

Leshno et al. [54]

Local

Local, international and estimations

International

NA

Industry

NR

Annual FOBT plus sigmoidoscopy during a 5-year interval was the best strategy with an ICER of NIS 1268/LYG

It is highly cost-effective to screen average-risk asymptomatic individuals beginning at age 50. One-time colonoscopic screening or FOBT plus sigmoidoscopy would be the preferred options

Lim et al. [55]

Pakistani, international and assumption

Pakistani and international

NR

NA

NGO

NR

Screening and treatment strategy will cost US$ 3.9 billion over 13 years with the yearly costs making up 9% of the annual health budget of Pakistan. This translates to about US$ 600/cure

Pakistan needs to invest up to 9% of its yearly health expenditure (0.11% of its GDP, or approximately US$ 1.50 /person/year) to achieve the WHO HCV-elimination target

Lohse et al. [56]

Local

International

International

NR

Industry

1 GDP/C (US$ 29,500 in 2010)

The full costs of universal screening of pregnant women was US$ 5887/DALY

GDM screening and postpartum lifestyle management have an attractive cost-effectiveness ratio

Madae’en et al. [57]

Jordanian

Jordanian

International

NA

None

1–3 GDP/C (US$ 4395–13,185 in 2019)

103,970 and 64,030 life years were gained using the Varenicline and NRT regimen compared to the no-intervention arm. The costs per LYG were US$ 1696 and US$ 1890 for Varenicline and NRT, respectively

Provision of Varenicline is a cost-effective intervention. Also, provision of NRT is likely to be cost-effective

Marseille et al. [58]

Local, international and assumptions

Local, international and estimations

International

International

Industry

1–3 GDP/C (US$ 29,800–89,400 in 2010)

The program cost/1000 pregnant women was US$ 259,929. The cost/DALY averted was US$ 1830

By WHO standards, GDM interventions are highly cost-effective

Mason et al. [59]

Local (from each country)

NR

International

NA

Academia and NGOs

NR

In all four countries most policies were cost saving compared with the baseline. The combination of all three policies resulted in estimated cost savings of US$ 235,000,000 and 6455 LYG in Tunisia; US$ 39,000,000 and 31,674 LYG in Syria; US$ 6,000,000 and 2682 LYG in Palestine and US$ 1,3000,000,000 and 378,439 LYG in Turkey

Reducing dietary salt intake will reduce CHD deaths in the four countries. Having a comprehensive health education strategy and food industry procedures for labeling and minimizing salt content would save money and lives

Messoudi et al. [60]

Moroccan, regional and international

Moroccan

International

NA

Government, academia, NGO and industry

1–3 GDP/C (US$ 2860–8580 in 2018)

The costs were US$ 551/LYS for current VIA screening and US$ 1150/LYS for HPV vaccination of pre-adolescent girls compared to no intervention. The cost of combined strategy of HPV vaccination and current screening was US$ 2843/LYS compared to screening alone

Current screening would be good value for money compared with no intervention but would be inefficient compared with vaccination

Mostafa et al. [61]

Egyptian

Egyptian

International

International

NGO

NR

Using Safety-engineered syringes was dominant option (less costly and more effective) with an ICER of US$ − 1802/QALY gained compared to conventional syringes

Using Safety-engineered syringes is more effective and cost-saving strategy

Mostafa et al. [62]

Egyptian

Egyptian and international

NR

International

NGO

NR

Using Safety-engineered syringes was dominant option (less costly and more effective) with an ICER of Int. $ − 18,650/QALY gained compared to conventional syringes

Using Safety-engineered syringes is cost saving prevention policy

Nahvijou et al. [63]

Iranian and assumptions

Iranian and international

Iranian and international

International

Academia

1–2 GDP/C (US$ 6631–13,262 in 2013)

Compared with no-screening strategy, the most cost-effective strategy (ICER of US$ 8875/QALY) was HPV DNA testing beginning at age 35 years with 10-year screening intervals

Organized cervical screening with HPV DNA testing for women is recommended, beginning at age 35 and repeated every 10 or 5 years

Okem et al. [64]

Turkish

Turkish

International

NA

NR

NR

ICER of NIPT was PPP 17,235,174/Down syndrome cases detected compared to combined test. ICER of NIPT following combined test was PPP 6,873,082/Down syndrome cases detected compared to combined test

NIPT leads to very high costs despite its high effectiveness. Thus, cost of NIPT should be decreased

Ornoy et al. [65]

Local and assumptions

Local

NA

NA

None

NA

The benefit cost ratio was 7.02 and, assuming only 50% success of treatment, it was 3.51

National screening program offers a very high cost benefit ratio

Ranson et al. [66]

Local, regional and international

Local, regional and international

Local, regional and international

NR

NGO

NR

Tax increases to raise the real price of cigarettes by 10% worldwide would prevent between 5 and 16 million tobacco-related deaths, and could cost US$ 3–70/DALY saved in LMIC. NRT and a package of non-price interventions other than NRT were also cost-effective in LMIC, at US$ 280–870 and US$ 36–710/DALY, respectively. In HIC, price increases were found to have a cost-effectiveness of US$ 83–2771/DALY, NRT US$ 750–7206/DALY and other non-price interventions US$ 696–13,924/DALY

Tobacco control policies, particularly tax increases on cigarettes, are cost-effective relative to other health interventions

Rashidian et al. [67]

Iranian

International

National

NA

Government

NR

Caspian-Alborz device was the most cost-effective alternative with an average cost-effectiveness from US$ 33 to 333/treatment of every one cubic meter of infectious waste in various conditions

There is more than one cost-effective device for different conditions and times in a country

Rezaei-Hemami et al. [68]

Iranian

Iranian and international

Iranian and international

NA

Academia

NR

The most cost-effective interventions were the use of insecticide-treated nets, Larviciding, surveillance for diagnosis and treatment of patients in less than 24 h, and indoor residual spraying, respectively

Insecticide-treated net is the most cost effective intervention

Saygili et al. [69]

Turkish

Local and international

NR

NA

NR

NR

From a societal perspective, palliative care services provided at hospital IPD were more cost‐effective. From a patient perspective, home healthcare was more cost‐effective with an ICER of US$ 33.43 and US$ -18.30/QALY compared to hospital IPD and comprehensive palliative care center, respectively

Hospital inpatient palliative care is more cost‐effective compared with other alternatives from societal perspective

Shamshiri et al. [70]

Iranian

Iranian

NR

Iranian

Academia

NR

ICERs for screening programs with different TSH cut-off points versus no screening were similar (US$ − 4.5 ± 0.2/DALY)

The current threshold of TSH in the national congenital hypothyroidism screening program is the most cost-effective threshold

Sharma et al. [71]

Lebanese and international

Lebanese

International

NA

None

1 GDP/C (Int. $ 17,462 in 2014)

ICERs/LYG were Int. $ 80,670 for annual cytologic screening at 20% coverage, Int. $ 12,210 for HPV DNA testing screening every 5 years at 50% coverage and Int. $ 16,340 for HPV DNA testing every 4 years at 50% coverage

Screening each 5 and 4 years is cost effective but annually is not

Shlomai et al. [72]

NR

Local

NA

NR

None

WTP of US$ 50,000–150,000

The ICER would be US$ 45.1 million/one death case prevented and US$ 15.24 million/QALY

A national lockdown strategy has a moderate advantage in saving lives with extremely high costs and possible overwhelming economic effects

Shmueli et al. [73]

Local

Local

International

Local

NGO and academia

WTP of US$ 10,000 and 20,000

ICER/QALY gained by screening was US$ 1464

Screening presents a good value for the money and should be considered for inclusion in the national list of health services financed publicly

Sladkevicius et al. [74]

Libyan

National, regional and international

International

NA

Industry

WTP of US$ 4,000

The expected cost/undiscounted LYG was US$ − 15,500. There would be a 90% return on investment in the screening program since society would gain US$ 1.9 for every invested US$ 1

Screening program is cost-effective from a societal perspective

Verguet et al. [75]

Regional and international

International

International

International

NR

1–3 GDP/C

ICERs/DALY were US$ 12,300 in Djibouti, 41,000 in Mauritania, 41,600 in Somalia and 19,600 in Sudan

Adding HIV pre-exposure prophylaxis is not cost-effective in Djibouti, Mauritania, Somalia, and Sudan due to low levels of HIV burden and high levels of male circumcision

Vijayaraghavan et al. [76]

National and international

National and international

International

NA

NR

1–3 GNI/C (US$ 735–2205 in 2002)

The cost/death prevented was US$ 23.6. For every one million US$ invested by donors, an estimated 42,300 deaths were prevented by the campaigns. For the same investment, the catch-up campaign averted 43,700 deaths while the follow-up campaign averted 38,300 deaths

The campaigns were extremely cost-effective and provided excellent returns on investment under all scenarios considered in the analysis

Vijayaraghavan et al. [77]

Somali

International

International

NA

Donors

1 GNI/C (US$ 140 in 2010)

The cost-effectiveness ratios were US$ 44/LYS by 1st round, US$ 28/LYS by 2nd round and US$ 34/LYS by both rounds combined. For every US$ 1 million invested in both rounds, an estimated 615 children’s lives, or 29,500 life years, were saved

Child Health Days are very cost-effective strategy for addressing the leading causes of children mortality in a conflict setting like Somalia

Wilcox et al. [78]

Syrian

Syrian

International

NA

Academia

PPP$ 13,000–38,997

CERs/LYG were PPP$ 5453 for reformulation of salt content within packaged foods, PPP$ 2201 for combination of health promotion campaign and reformulation of salt content and PPP$ 2125 for combination of reformulation of salt content and labeling of salt content on packaged foods

All salt reduction policies are cost-saving or cost effective

Yarahmadi et al. [79]

NR

Local

International

NA

NR

NR

Benefit to cost ratios with regard to education and care of patients with mental retardation were lower by 22 times (100% in the public sector), 41 times (100% in the private sector), 32 times (50% in the public sector and 50% in the private sector), 34 times (100% in the public sector day and night), 47 times (50% in the public sector and 50% in the private sector day and night), and 60 times (100% in the private sector day and night)

Newborn screening program for congenital hypothyroidism has been quite effective

Yosefy et al. [80]

Local

Local and International

NR

Local

NR

1–3 GDP/C (US$ 16,497–49,491 in 2003)

The implementation of health education program nationwide was likely to save over 2000 lives and US$ 185 million in health care resources alone

It is conceivable that the health education program may be extended not only throughout this country, but also to neighboring countries

Yosefy et al. [81]

Local

NR

Local

International

Government

NR

The net saving to health services would be US$ 977,993 and the increase in QALYs would be 602 years

Better control of hypertensive patients is cost effective

  1. 3HP 3 months of weekly rifapentine 900 mg plus isoniazid 900 mg, HBcAb hepatitis B core antibody, HBsAg hepatitis B surface antigen, CBA cost–benefit analysis, CEA cost-effectiveness analysis, CER cost-effectiveness ratio, CHB chronic hepatitis B, CHD coronary heart disease, CMA cost-minimization analysis, CUA cost-utility analysis, CVDs cardiovascular diseases, CXR chest X-ray, DALYs disability adjusted life years, DM diabetes mellitus, ECG electrocardiogram, EGCRISC Egyptian hepatitis C virus risk score screening tool, FOBT fecal occult blood test, G6PD glucose-6-phosphate dehydrogenase, GDM gestational diabetes mellitus, GDP/C gross domestic product per capita, GNI/C gross national income per capita, GNP/C gross national product per capita, HBV hepatitis B virus, HCC hepatocellular carcinoma, HCV hepatitis C virus, HCWs healthcare workers, HIC high income countries, HIV human immunodeficiency virus, HPV human papillomavirus, HPV-DNA human papillomavirus DNA assay, ICER incremental cost-effectiveness ratio, IGRA interferon gamma release assay, Int. $ international dollar, IPD inpatient department, LE Egyptian pound, LMIC low and middle income countries, LYG life years gained, LYS life years saved, NA not applicable, NCDs noncommunicable diseases, NGO non-governmental organization (non-for-profit), NIPT non-invasive prenatal testing, NIS New Israeli Shekels, NR not reported, NRT nicotine replacement therapy, Pap-smear Papanicolaou test, QALYs quality-adjusted life years, QFT-Plus QuantiFERON-TB gold plus, PPP purchasing power parity, SR Saudi Riyal, TB tuberculosis, TSH thyroid stimulating hormone, TST tuberculin skin test, VIA visual inspection with acetic acid, WHO World Health Organization, WHO-CHOICE World Health Organization-CHOosing Interventions that are Cost-Effective, WTP willingness-to-pay